Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients

Background: Hepatocellular carcinoma [HCC] is one of the leading causes of cancer-related deaths worldwide. A major problem with HCC surveillance is the lack of reliable biomarkers. Serum transthyretin [TTR] may be a sensitive marker for the diagnosis of patients with liver cell damage, liver cirrho...

Full description

Bibliographic Details
Main Authors: Magda Ibrahim, Fathiya El-Raey, Naglaa Fathy, Kadrey El-Bakrey
Format: Article
Language:English
Published: Egyptian knowledge bank 2020-04-01
Series:International Journal of Medical Arts
Subjects:
Online Access:https://ijma.journals.ekb.eg/article_82380_37df342f1483d981733ec70d834c8af1.pdf

Similar Items